Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-05-12 | 2022-09-08 | 160445 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-08-18 | 2023-07-21 | 167209 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-30 | 2022-10-29 | 170764 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-11 | 2024-08-01 | 215760 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-02-29 | 2024-12-19 | 220986 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-04-11 | 2024-10-17 | 224886 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-12-19 | 2025-03-27 | 246104 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2025-02-13 | 2025-12-11 | 250393 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-09-05 | 2019-09-27 | 93134 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2020-03-06 | 2020-05-14 | 107992 |
| TEVA-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-05-14 | 109577 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-06-30 | 2022-10-18 | 163951 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2025-12-04 | 2025-12-04 | 273302 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-08 | 110712 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-08 | 110716 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-09 | 110719 |
| TEVA-MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-04-23 | 110722 |
| TEVA-MORPHINE SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-08 | 110725 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |